Literature DB >> 6343504

Competitive inhibition enzyme immunoassays for the measurement of human IgG, IgA and IgM.

I J Smart, L Y Koh.   

Abstract

Competitive-inhibition enzyme immunoassays for the measurement of human IgG, IgA and IgM are described. These assays can be readily performed with commercial antisera and a recently developed method for purifying human IgA and IgM with high yield. The assays described are specific, with undetectable (less than 0.5%) cross-reactivity between the immunoglobulin classes in all systems, except with purified IgM, which cross-reacted to 1.9% with the IgG enzyme immunoassay. Minimal detectable concentrations of 2.5 +/- 0.8 ng/ml for IgG, 4.2 +/- 0.9 ng/ml for IgA and 7.2 +/- 1.4 ng/ml for IgM were recorded, indicating that these assays are particularly sensitive. There is little within-assay variation (mean coefficient of variation = 3.9%), although the between-assay variation was substantially greater (mean coefficient of variation = 23.5%). These assay systems appear to be particularly suited to the measurement of immunoglobulin production by lymphocytes in culture. In such studies the assay must be specific, sensitive and be capable of discriminating between levels of immunoglobulin produced in response to various experimental treatments.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6343504     DOI: 10.1016/0022-1759(83)90290-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Immunoglobulin profile of tracheal aspirate fluid in intubated children.

Authors:  K Forsyth; L Koh; A Lawrence; J Bradley
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

2.  A class capture enzyme immunoassay for immunoglobulin level determinations in bovine sera.

Authors:  K Nielsen; B Rosenbaum; J Stiller
Journal:  Can J Comp Med       Date:  1985-10

3.  Responses of 'mature' human B lymphocyte lines to inducers of maturation and activation.

Authors:  H Zola; V Griffith; I Hunter; L Koh; J Bradley
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

4.  Lung immunoglobulins in the sudden infant death syndrome.

Authors:  K D Forsyth; S C Weeks; L Koh; J Skinner; J Bradley
Journal:  BMJ       Date:  1989-01-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.